SlideShare ist ein Scribd-Unternehmen logo
1 von 30
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human Cell Systems Ellen L. Berg, PhD BioSeek, Inc. eChemInfo, Philadelphia PA October 2009 Bio Seek
Presentation Overview ,[object Object],[object Object],[object Object],[object Object],[object Object]
Biological Systems Are Complex Scale (meters)  (Time) 10 -9  M 10 -8  M 10 -7  M 10 -6  M 10 -5  M 10 -4  M 10 -3  M 10 -2  M 10 -1  M 1 M Human exposure Molecular targets  10 -6  sec 10 2  sec 10 4  sec 10 5  sec 10 8  sec Modular design / Networked architecture molecules pathways cells tissues humans
Biological Systems have a Modular Design ,[object Object],[object Object],[object Object],[object Object],Scale (meters)  (Time) molecules pathways cells tissues humans 10 -9  M 10 -8  M 10 -7  M 10 -6  M 10 -5  M 10 -4  M 10 -3  M 10 -2  M 10 -1  M 1 M 10 -6  sec 10 2  sec 10 4  sec 10 5  sec 10 8  sec components interactions
Biological Systems have a Networked Architecture ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],components interactions Scale (meters)  (Time) molecules pathways cells tissues humans 10 -9  M 10 -8  M 10 -7  M 10 -6  M 10 -5  M 10 -4  M 10 -3  M 10 -2  M 10 -1  M 1 M 10 -6  sec 10 2  sec 10 4  sec 10 5  sec 10 8  sec
Biological Systems are Dominated by Control Systems ,[object Object],[object Object],[object Object],[object Object],Scale (meters)  (Time) molecules pathways cells tissues humans 10 -9  M 10 -8  M 10 -7  M 10 -6  M 10 -5  M 10 -4  M 10 -3  M 10 -2  M 10 -1  M 1 M 10 -6  sec 10 2  sec 10 4  sec 10 5  sec 10 8  sec components interactions
Modular, Networked Architecture Consequences for Drug Discovery & Predictive Toxicology ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
BioMAP ®  Technology   Bridging the Gap Scale (meters)  (Time) 10 -9  M 10 -8  M 10 -7  M 10 -6  M 10 -5  M 10 -4  M 10 -3  M 10 -2  M 10 -1  M 1 M Human exposure Molecular targets  10 -6  sec 10 2  sec 10 4  sec 10 5  sec 10 8  sec BioMAP Technology molecules pathways cells tissues humans
BioMAP ®   Technology Platform Assays Human primary cells  Disease-like culture conditions LPS BF4T SM3C Profile Database Informatics Biological responses to drugs and stored in the database Specialized informatics tools are used to mine and analyze biological data
[object Object],[object Object],[object Object],[object Object],BioMAP ®   Technology Platform Assays Human primary cells  Disease-like culture conditions >30 BioMAP Systems LPS BF4T SM3C
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BioMAP ®   Technology Platform Assays Human primary cells  Disease-like culture conditions >30 BioMAP Systems LPS BF4T SM3C
Assays Human primary cells  Disease-like culture conditions Profile Database Biological responses to drugs and stored in the database BioMAP ®   Technology Platform ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],LPS BF4T SM3C
BioMAP Systems are Validated   Corticosteroids (Prednisolone) Are Active in Inflammation Systems Profiles retain shape over multiple concentrations BioMAP Systems Readout Parameters (Biomarkers) Cytotoxicity Readouts Log expression ratio (Drug/DMSO control) Control (no drug) 99% significance  envelope Dose Response
E-selectin TNF-  IL-8 BioMAP Systems are Validated  Activities of Corticosteroids Match Clinical Effects PGE 2 IL-8 MCP-1 Readouts in BioMAP show the same pattern as has been reported for patients receiving steroid therapy  Log expression ratio (Drug/DMSO control) MCP-1, IL-8, E-sel. decrease Leukocyte recruitment Many, e.g. Jilma et al., 2000 PGE 2  decrease Pain, swelling Sebaldt et al., 1990 Collagen I & III Collagen I, III decrease Skin atrophy Autio et al., 1994 MMP-1 PAI-1 SAA PAI-1, SAA increase CV complications Sartori et al., 1999 Fyfe et al., 1997 PAI-1
Predictive Toxicology ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Microtubule Stabilizers Mitochondrial  ET chain Retinoids Hsp90 CDK NF  B MEK DNA synthesis JNK Protein synthesis Microtubule Destabilizers Estrogen R PI-3K Ca ++ Mobilization Classification of Drugs By Mechanism  Pairwise Correlation of BioMAP Reveals Functional Similarities  mTOR PKC Activation p38 MAPK HMG-CoA reductase Calcineurin Transcription Mechanism of Action (On-Target) Pathway Relationships
Defining Toxicity Mechanisms   Sodium Azide Chlorambucil  Cycloheximide  A23187 Thapsigargin Oxidative /Nitrosative Stress ER Stress Unfolded Protein Response Rotenone
ToxCast Chemicals Diversity of Mechanisms Houck, 2009
BioMAP Profiles of Compounds in Example Cluster ,[object Object],[object Object],Tryfloxystrobin Pyraclostrobin Pyraclostrobin, 13.33   M Pyraclostrobin, 4.44   M Pyraclostrobin, 1.48   M Tryfloxystrobin, 40   M Tryfloxystrobin, 13.33   M Tryfloxystrobin, 4.44   M
Reference Database Search Identifies MOA Tryfloxystrobin Search results: ,[object Object],[object Object],Trifluoxystrobin
[object Object],[object Object],Reference Database Search Identifies MOA Search results: ,[object Object],[object Object],Tryfloxystrobin Trifluoxystrobin
ToxCast Chemicals Diversity of Mechanisms cAMP Elevation DNA Alkylation NF  B Tubulin Inhibition  Mitochondrial Dysfunction
Challenges for Predictive Toxicology Applications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Cytotoxicity Effects ,[object Object],[object Object],Toxicity Cell Type Endothelial Cells Epithelial Cells SMC Fibroblasts EC Activation State
Concentration Effects Log expression ratio (Compound /DMSO control) Rapamycin Genistein ,[object Object],Readout Parameters (Biomarkers) BioMAP Systems Readout Parameters (Biomarkers) BioMAP Systems
Concentration Effects ,[object Object],[object Object],[object Object],Rapamycin Genistein No effect Max Inhibition Increasing Concentration Increasing Concentration Cytotoxicity HLA-DR Levels Plateau EC 50 Magnitude
Concentration Effects ,[object Object],No effect Max Inhibition Increasing Concentration Readout Levels
Summary ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Acknowledgements ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 

Weitere ähnliche Inhalte

Was ist angesagt?

Overview Radboudumc Center for Proteomics, Glycomics and Metabolomics april 2015
Overview Radboudumc Center for Proteomics, Glycomics and Metabolomics april 2015Overview Radboudumc Center for Proteomics, Glycomics and Metabolomics april 2015
Overview Radboudumc Center for Proteomics, Glycomics and Metabolomics april 2015Alain van Gool
 
Metabolomics
MetabolomicsMetabolomics
Metabolomicspriya1111
 
proteomics, mass spectrometry, science, bioinformatics, electrophoresis, liqu...
proteomics, mass spectrometry, science, bioinformatics, electrophoresis, liqu...proteomics, mass spectrometry, science, bioinformatics, electrophoresis, liqu...
proteomics, mass spectrometry, science, bioinformatics, electrophoresis, liqu...Amit Yadav
 
Vijay protiomics current
Vijay protiomics currentVijay protiomics current
Vijay protiomics currentRohit Bisht
 
Proteomics course 1
Proteomics course 1Proteomics course 1
Proteomics course 1utpaltatu
 
A brief introfuction of label-free protein quantification methods
A brief introfuction of label-free protein quantification methodsA brief introfuction of label-free protein quantification methods
A brief introfuction of label-free protein quantification methodsCreative Proteomics
 
Proteome analysis
Proteome analysisProteome analysis
Proteome analysisAkash Verma
 
APTAMERS
APTAMERS APTAMERS
APTAMERS ROHIT
 
Stratified Medicine in Cancer: The Role of Histopathologist
Stratified Medicine in Cancer: The Role of HistopathologistStratified Medicine in Cancer: The Role of Histopathologist
Stratified Medicine in Cancer: The Role of HistopathologistDr. Shubhi Saxena
 
Application of proteomics for identification of abiotic stress tolerance in c...
Application of proteomics for identification of abiotic stress tolerance in c...Application of proteomics for identification of abiotic stress tolerance in c...
Application of proteomics for identification of abiotic stress tolerance in c...Vivek Zinzala
 
itraq protein quatification technique
 itraq protein quatification technique itraq protein quatification technique
itraq protein quatification techniquebharti rakhecha
 
General Principles of Toxicogenomics
General Principles of ToxicogenomicsGeneral Principles of Toxicogenomics
General Principles of Toxicogenomicscwoodland
 
Assignment on Genotoxicity
Assignment on GenotoxicityAssignment on Genotoxicity
Assignment on GenotoxicityDeepak Kumar
 
Peptide Mass Fingerprinting (PMF) and Isotope Coded Affinity Tags (ICAT)
Peptide Mass Fingerprinting  (PMF) and Isotope Coded Affinity Tags (ICAT)Peptide Mass Fingerprinting  (PMF) and Isotope Coded Affinity Tags (ICAT)
Peptide Mass Fingerprinting (PMF) and Isotope Coded Affinity Tags (ICAT)Suresh Antre
 

Was ist angesagt? (20)

Overview Radboudumc Center for Proteomics, Glycomics and Metabolomics april 2015
Overview Radboudumc Center for Proteomics, Glycomics and Metabolomics april 2015Overview Radboudumc Center for Proteomics, Glycomics and Metabolomics april 2015
Overview Radboudumc Center for Proteomics, Glycomics and Metabolomics april 2015
 
Metabolomics
MetabolomicsMetabolomics
Metabolomics
 
proteomics, mass spectrometry, science, bioinformatics, electrophoresis, liqu...
proteomics, mass spectrometry, science, bioinformatics, electrophoresis, liqu...proteomics, mass spectrometry, science, bioinformatics, electrophoresis, liqu...
proteomics, mass spectrometry, science, bioinformatics, electrophoresis, liqu...
 
Vijay protiomics current
Vijay protiomics currentVijay protiomics current
Vijay protiomics current
 
Proteomics course 1
Proteomics course 1Proteomics course 1
Proteomics course 1
 
A brief introfuction of label-free protein quantification methods
A brief introfuction of label-free protein quantification methodsA brief introfuction of label-free protein quantification methods
A brief introfuction of label-free protein quantification methods
 
Proteomic and metabolomic
Proteomic and metabolomicProteomic and metabolomic
Proteomic and metabolomic
 
Directed evolution
Directed evolutionDirected evolution
Directed evolution
 
Proteomics
ProteomicsProteomics
Proteomics
 
Brian_Strahl 2013_class_on_genomics_and_proteomics
Brian_Strahl 2013_class_on_genomics_and_proteomicsBrian_Strahl 2013_class_on_genomics_and_proteomics
Brian_Strahl 2013_class_on_genomics_and_proteomics
 
Aptamers
AptamersAptamers
Aptamers
 
Proteome analysis
Proteome analysisProteome analysis
Proteome analysis
 
APTAMERS
APTAMERS APTAMERS
APTAMERS
 
Stratified Medicine in Cancer: The Role of Histopathologist
Stratified Medicine in Cancer: The Role of HistopathologistStratified Medicine in Cancer: The Role of Histopathologist
Stratified Medicine in Cancer: The Role of Histopathologist
 
Application of proteomics for identification of abiotic stress tolerance in c...
Application of proteomics for identification of abiotic stress tolerance in c...Application of proteomics for identification of abiotic stress tolerance in c...
Application of proteomics for identification of abiotic stress tolerance in c...
 
Proteomics
ProteomicsProteomics
Proteomics
 
itraq protein quatification technique
 itraq protein quatification technique itraq protein quatification technique
itraq protein quatification technique
 
General Principles of Toxicogenomics
General Principles of ToxicogenomicsGeneral Principles of Toxicogenomics
General Principles of Toxicogenomics
 
Assignment on Genotoxicity
Assignment on GenotoxicityAssignment on Genotoxicity
Assignment on Genotoxicity
 
Peptide Mass Fingerprinting (PMF) and Isotope Coded Affinity Tags (ICAT)
Peptide Mass Fingerprinting  (PMF) and Isotope Coded Affinity Tags (ICAT)Peptide Mass Fingerprinting  (PMF) and Isotope Coded Affinity Tags (ICAT)
Peptide Mass Fingerprinting (PMF) and Isotope Coded Affinity Tags (ICAT)
 

Ähnlich wie Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human Cell Systems

BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug DiscoveryBioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug DiscoveryBioMAP® Systems
 
Predictive Models for Mechanism of Action Classification from Phenotypic Assa...
Predictive Models for Mechanism of Action Classification from Phenotypic Assa...Predictive Models for Mechanism of Action Classification from Phenotypic Assa...
Predictive Models for Mechanism of Action Classification from Phenotypic Assa...Ellen Berg
 
Interactomics, Integromics to Systems Biology: Next Animal Biotechnology Fron...
Interactomics, Integromics to Systems Biology: Next Animal Biotechnology Fron...Interactomics, Integromics to Systems Biology: Next Animal Biotechnology Fron...
Interactomics, Integromics to Systems Biology: Next Animal Biotechnology Fron...Varij Nayan
 
Grafström - Lush Prize Conference 2014
Grafström - Lush Prize Conference 2014Grafström - Lush Prize Conference 2014
Grafström - Lush Prize Conference 2014LushPrize
 
Drug metabolism and toxicity 2013
Drug metabolism and toxicity 2013Drug metabolism and toxicity 2013
Drug metabolism and toxicity 2013Elsa von Licy
 
Berg ellen cal epa 29 oct2014
Berg ellen cal epa 29 oct2014Berg ellen cal epa 29 oct2014
Berg ellen cal epa 29 oct2014Ellen Berg
 
Nc state lecture v2 Computational Toxicology
Nc state lecture v2 Computational ToxicologyNc state lecture v2 Computational Toxicology
Nc state lecture v2 Computational ToxicologySean Ekins
 
Berg ellen slas 2015 11_february2015
Berg ellen slas 2015 11_february2015Berg ellen slas 2015 11_february2015
Berg ellen slas 2015 11_february2015Ellen Berg
 
Proteomics in VSC for crop improvement programme
Proteomics in VSC for crop improvement programmeProteomics in VSC for crop improvement programme
Proteomics in VSC for crop improvement programmeSumanthBT1
 
Genomics and proteomics in drug discovery and development
Genomics and proteomics in drug discovery and developmentGenomics and proteomics in drug discovery and development
Genomics and proteomics in drug discovery and developmentSuchittaU
 
Proteomics and its applications in phytopathology
Proteomics and its applications in phytopathologyProteomics and its applications in phytopathology
Proteomics and its applications in phytopathologyAbhijeet Kashyap
 
Berg Ellen univ_pugetsound_12feb2015
Berg Ellen univ_pugetsound_12feb2015Berg Ellen univ_pugetsound_12feb2015
Berg Ellen univ_pugetsound_12feb2015Ellen Berg
 
Genomics, Transcriptomics, Proteomics, Metabolomics - Basic concepts for clin...
Genomics, Transcriptomics, Proteomics, Metabolomics - Basic concepts for clin...Genomics, Transcriptomics, Proteomics, Metabolomics - Basic concepts for clin...
Genomics, Transcriptomics, Proteomics, Metabolomics - Basic concepts for clin...Prasenjit Mitra
 
bioinformatics simple
bioinformatics simple bioinformatics simple
bioinformatics simple nadeem akhter
 
Vanderwall cheminformatics Drexel Part 1
Vanderwall cheminformatics Drexel Part 1Vanderwall cheminformatics Drexel Part 1
Vanderwall cheminformatics Drexel Part 1Jean-Claude Bradley
 
Berg ellen 7th braz medchem 12nov2014
Berg ellen 7th braz medchem 12nov2014Berg ellen 7th braz medchem 12nov2014
Berg ellen 7th braz medchem 12nov2014Ellen Berg
 

Ähnlich wie Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human Cell Systems (20)

BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug DiscoveryBioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
 
Predictive Models for Mechanism of Action Classification from Phenotypic Assa...
Predictive Models for Mechanism of Action Classification from Phenotypic Assa...Predictive Models for Mechanism of Action Classification from Phenotypic Assa...
Predictive Models for Mechanism of Action Classification from Phenotypic Assa...
 
Toxicity testing
Toxicity testingToxicity testing
Toxicity testing
 
2013 10 23_dna_for_dummies_v_presented
2013 10 23_dna_for_dummies_v_presented2013 10 23_dna_for_dummies_v_presented
2013 10 23_dna_for_dummies_v_presented
 
Interactomics, Integromics to Systems Biology: Next Animal Biotechnology Fron...
Interactomics, Integromics to Systems Biology: Next Animal Biotechnology Fron...Interactomics, Integromics to Systems Biology: Next Animal Biotechnology Fron...
Interactomics, Integromics to Systems Biology: Next Animal Biotechnology Fron...
 
Grafström - Lush Prize Conference 2014
Grafström - Lush Prize Conference 2014Grafström - Lush Prize Conference 2014
Grafström - Lush Prize Conference 2014
 
Drug metabolism and toxicity 2013
Drug metabolism and toxicity 2013Drug metabolism and toxicity 2013
Drug metabolism and toxicity 2013
 
Berg ellen cal epa 29 oct2014
Berg ellen cal epa 29 oct2014Berg ellen cal epa 29 oct2014
Berg ellen cal epa 29 oct2014
 
Nc state lecture v2 Computational Toxicology
Nc state lecture v2 Computational ToxicologyNc state lecture v2 Computational Toxicology
Nc state lecture v2 Computational Toxicology
 
Berg ellen slas 2015 11_february2015
Berg ellen slas 2015 11_february2015Berg ellen slas 2015 11_february2015
Berg ellen slas 2015 11_february2015
 
Proteomics in VSC for crop improvement programme
Proteomics in VSC for crop improvement programmeProteomics in VSC for crop improvement programme
Proteomics in VSC for crop improvement programme
 
Genomics and proteomics in drug discovery and development
Genomics and proteomics in drug discovery and developmentGenomics and proteomics in drug discovery and development
Genomics and proteomics in drug discovery and development
 
Proteomics and its applications in phytopathology
Proteomics and its applications in phytopathologyProteomics and its applications in phytopathology
Proteomics and its applications in phytopathology
 
Berg Ellen univ_pugetsound_12feb2015
Berg Ellen univ_pugetsound_12feb2015Berg Ellen univ_pugetsound_12feb2015
Berg Ellen univ_pugetsound_12feb2015
 
Genomics, Transcriptomics, Proteomics, Metabolomics - Basic concepts for clin...
Genomics, Transcriptomics, Proteomics, Metabolomics - Basic concepts for clin...Genomics, Transcriptomics, Proteomics, Metabolomics - Basic concepts for clin...
Genomics, Transcriptomics, Proteomics, Metabolomics - Basic concepts for clin...
 
bioinformatics simple
bioinformatics simple bioinformatics simple
bioinformatics simple
 
Proteomics
ProteomicsProteomics
Proteomics
 
Metabolomics.ppt
Metabolomics.pptMetabolomics.ppt
Metabolomics.ppt
 
Vanderwall cheminformatics Drexel Part 1
Vanderwall cheminformatics Drexel Part 1Vanderwall cheminformatics Drexel Part 1
Vanderwall cheminformatics Drexel Part 1
 
Berg ellen 7th braz medchem 12nov2014
Berg ellen 7th braz medchem 12nov2014Berg ellen 7th braz medchem 12nov2014
Berg ellen 7th braz medchem 12nov2014
 

Mehr von BioMAP® Systems

BioSeek Presentation at the 2012 Inflammation Res Assoc. Conference
BioSeek Presentation at the 2012 Inflammation Res Assoc. ConferenceBioSeek Presentation at the 2012 Inflammation Res Assoc. Conference
BioSeek Presentation at the 2012 Inflammation Res Assoc. ConferenceBioMAP® Systems
 
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...BioMAP® Systems
 
Primary Human Cell Systems Analysis of Drug Mechanisms
Primary Human Cell Systems Analysis of Drug MechanismsPrimary Human Cell Systems Analysis of Drug Mechanisms
Primary Human Cell Systems Analysis of Drug MechanismsBioMAP® Systems
 
BioSeek EPA ToxCast Program
BioSeek EPA ToxCast ProgramBioSeek EPA ToxCast Program
BioSeek EPA ToxCast ProgramBioMAP® Systems
 
Diversity Plus Panel of BioMAP<sup>®</sup> Systems
Diversity Plus Panel of BioMAP<sup>®</sup> SystemsDiversity Plus Panel of BioMAP<sup>®</sup> Systems
Diversity Plus Panel of BioMAP<sup>®</sup> SystemsBioMAP® Systems
 
Introduction to BioMAP<sup>®</sup> Systems
Introduction to BioMAP<sup>®</sup> SystemsIntroduction to BioMAP<sup>®</sup> Systems
Introduction to BioMAP<sup>®</sup> SystemsBioMAP® Systems
 
Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi...
Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi...Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi...
Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi...BioMAP® Systems
 
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...Methods and Approaches for Defining Mechanism Signatures from Human Primary C...
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...BioMAP® Systems
 
Primary Human Cell Systems Analysis of Drug Mechanisms
Primary Human Cell Systems Analysis of Drug MechanismsPrimary Human Cell Systems Analysis of Drug Mechanisms
Primary Human Cell Systems Analysis of Drug MechanismsBioMAP® Systems
 

Mehr von BioMAP® Systems (9)

BioSeek Presentation at the 2012 Inflammation Res Assoc. Conference
BioSeek Presentation at the 2012 Inflammation Res Assoc. ConferenceBioSeek Presentation at the 2012 Inflammation Res Assoc. Conference
BioSeek Presentation at the 2012 Inflammation Res Assoc. Conference
 
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
 
Primary Human Cell Systems Analysis of Drug Mechanisms
Primary Human Cell Systems Analysis of Drug MechanismsPrimary Human Cell Systems Analysis of Drug Mechanisms
Primary Human Cell Systems Analysis of Drug Mechanisms
 
BioSeek EPA ToxCast Program
BioSeek EPA ToxCast ProgramBioSeek EPA ToxCast Program
BioSeek EPA ToxCast Program
 
Diversity Plus Panel of BioMAP<sup>®</sup> Systems
Diversity Plus Panel of BioMAP<sup>®</sup> SystemsDiversity Plus Panel of BioMAP<sup>®</sup> Systems
Diversity Plus Panel of BioMAP<sup>®</sup> Systems
 
Introduction to BioMAP<sup>®</sup> Systems
Introduction to BioMAP<sup>®</sup> SystemsIntroduction to BioMAP<sup>®</sup> Systems
Introduction to BioMAP<sup>®</sup> Systems
 
Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi...
Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi...Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi...
Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi...
 
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...Methods and Approaches for Defining Mechanism Signatures from Human Primary C...
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...
 
Primary Human Cell Systems Analysis of Drug Mechanisms
Primary Human Cell Systems Analysis of Drug MechanismsPrimary Human Cell Systems Analysis of Drug Mechanisms
Primary Human Cell Systems Analysis of Drug Mechanisms
 

Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human Cell Systems

  • 1. Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human Cell Systems Ellen L. Berg, PhD BioSeek, Inc. eChemInfo, Philadelphia PA October 2009 Bio Seek
  • 2.
  • 3. Biological Systems Are Complex Scale (meters) (Time) 10 -9 M 10 -8 M 10 -7 M 10 -6 M 10 -5 M 10 -4 M 10 -3 M 10 -2 M 10 -1 M 1 M Human exposure Molecular targets 10 -6 sec 10 2 sec 10 4 sec 10 5 sec 10 8 sec Modular design / Networked architecture molecules pathways cells tissues humans
  • 4.
  • 5.
  • 6.
  • 7.
  • 8. BioMAP ® Technology Bridging the Gap Scale (meters) (Time) 10 -9 M 10 -8 M 10 -7 M 10 -6 M 10 -5 M 10 -4 M 10 -3 M 10 -2 M 10 -1 M 1 M Human exposure Molecular targets 10 -6 sec 10 2 sec 10 4 sec 10 5 sec 10 8 sec BioMAP Technology molecules pathways cells tissues humans
  • 9. BioMAP ® Technology Platform Assays Human primary cells Disease-like culture conditions LPS BF4T SM3C Profile Database Informatics Biological responses to drugs and stored in the database Specialized informatics tools are used to mine and analyze biological data
  • 10.
  • 11.
  • 12.
  • 13. BioMAP Systems are Validated Corticosteroids (Prednisolone) Are Active in Inflammation Systems Profiles retain shape over multiple concentrations BioMAP Systems Readout Parameters (Biomarkers) Cytotoxicity Readouts Log expression ratio (Drug/DMSO control) Control (no drug) 99% significance envelope Dose Response
  • 14. E-selectin TNF-  IL-8 BioMAP Systems are Validated Activities of Corticosteroids Match Clinical Effects PGE 2 IL-8 MCP-1 Readouts in BioMAP show the same pattern as has been reported for patients receiving steroid therapy Log expression ratio (Drug/DMSO control) MCP-1, IL-8, E-sel. decrease Leukocyte recruitment Many, e.g. Jilma et al., 2000 PGE 2 decrease Pain, swelling Sebaldt et al., 1990 Collagen I & III Collagen I, III decrease Skin atrophy Autio et al., 1994 MMP-1 PAI-1 SAA PAI-1, SAA increase CV complications Sartori et al., 1999 Fyfe et al., 1997 PAI-1
  • 15.
  • 16. Microtubule Stabilizers Mitochondrial ET chain Retinoids Hsp90 CDK NF  B MEK DNA synthesis JNK Protein synthesis Microtubule Destabilizers Estrogen R PI-3K Ca ++ Mobilization Classification of Drugs By Mechanism Pairwise Correlation of BioMAP Reveals Functional Similarities mTOR PKC Activation p38 MAPK HMG-CoA reductase Calcineurin Transcription Mechanism of Action (On-Target) Pathway Relationships
  • 17. Defining Toxicity Mechanisms Sodium Azide Chlorambucil Cycloheximide A23187 Thapsigargin Oxidative /Nitrosative Stress ER Stress Unfolded Protein Response Rotenone
  • 18. ToxCast Chemicals Diversity of Mechanisms Houck, 2009
  • 19.
  • 20.
  • 21.
  • 22. ToxCast Chemicals Diversity of Mechanisms cAMP Elevation DNA Alkylation NF  B Tubulin Inhibition Mitochondrial Dysfunction
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.  

Hinweis der Redaktion

  1. 2 1
  2. BioMAP systems are complex primary human cell based disease models that can be used directly for phenotypic screening. The most attractive feature of this platform, however, is it’s ability of the platform to provide target and pathway mechanisms of action. This enables reverse pharmacology of bioactive agents and drugs as well as in depth characterization of leads for identifying on versus off-target biology, which in turn impact safety and also clinical indication selection.
  3. The complexity of biological systems makes it difficult to predict outcomes from both target-based as well as phenotypic drug discovery efforts. The BioMAP platform of cell-based assay platform designed to include more of the biological complexity of human disease, but yet in a practical format with sufficient throughput to be used in early discovery. So what do we mean by biological complexity?
  4. BioMAP systems are complex primary human cell based disease models that can be used directly for phenotypic screening. The most attractive feature of this platform, however, is it’s ability of the platform to provide target and pathway mechanisms of action. This enables reverse pharmacology of bioactive agents and drugs as well as in depth characterization of leads for identifying on versus off-target biology, which in turn impact safety and also clinical indication selection.